Manhattan Bridge Capital, Inc.
NASDAQ: LOAN
Manhattan Bridge Capital: A 10% Dividend Our Model Won’t Buy
Finrys snapshot · FY2025
OVERVALUED$4.30
Price
$3.77
Fair value
9.8×
P/E
10.2%
Dividend yield
Manhattan Bridge Capital is a $49.2 million company that lends money to house-flippers in New York. It pays a 10.2% dividend, trades on 9.8× earnings, passes seven of our eight health pillars — and in 1,340+ loans since 2007 it has never once foreclosed on a property. It also earns a verdict of Overvalued from our model and a 1-out-of-5 predictability score. That contradiction is the whole story — and resolving it takes you somewhere no ratio on the report can: into a single footnote of the 10-K.
Open the live LOAN report on Finrys →The business
How a hard-money lender makes money
Forget the name — this is not a bank and it owns no buildings. It is a bridge lender: a house-flipper finds a property, needs cash in days rather than the weeks a mortgage takes, and pays a high rate for the speed. Manhattan Bridge writes the cheque, takes the house as collateral, collects interest for about a year, and gets its money back when the flipper sells or refinances. Three things make that work.
The loan
Short-term first-mortgage loans to house-flippers and small developers: a fixed 11.12% average rate, interest-only, typically a one-year term, plus a 0–2% origination fee. Speed is the product — borrowers pay up because a bank cannot close in days.
The collateral
A first lien at no more than 75% loan-to-value, plus a personal guarantee from the borrower’s principals. No single loan may exceed the lower of 9.9% of the book or $4 million — so one bad deal cannot take the company down.
The funding
They borrow at ~6.7–7.3% on two bank lines and lend at ~11.12%, keeping the spread. Only $17.6M is drawn against $43.1M of equity — leverage of just 0.45×, which is unusually tame for a lender.
As a REIT, the company pays almost no corporate tax — on condition that it hands at least 90% of its taxable income to shareholders. That is why the dividend is the product here. You are not buying growth; you are buying a slice of an interest-rate spread, paid out to you four times a year.
Quality
Profitable, disciplined — and utterly unpredictable
The profitability is real: about 59 cents of every revenue dollar reaches net income, on a 11.6% return on capital and a 12% return on equity. Those are honest numbers for a lender running at just 0.45× leverage. But look at the fourth card.
11.6%
ROIC (5y)
12%
Return on equity
59%
Net margin
1/5 ★
Predictability
Finrys health check
7 of 8 pillars passed
Every stock on Finrys runs through a Graham-inspired 8-point quality checklist before any valuation. Manhattan Bridge passes seven — cheap on earnings, cheap on cash flow, high returns, no dilution, almost no debt. It fails exactly one, and it fails it by a whisker: profit is up 15.6% over five years against a 20% bar.
- ✓
TTM P/E
You’re not overpaying — the price is sensible relative to current earnings.
9.6×
TTM P/E < 22.5×
- ✕
Growing Profits
Bottom-line profit is higher than it was five years ago.
+15.6%
5Y net income growth ≥ 20%
- ✓
High Return on Capital
The business earns a strong return on the capital invested in it.
+11.6%
5Y ROIC > 9%
- ✓
Growing Sales
The top line is growing — the company sells more than it used to.
+27.3%
5Y revenue growth ≥ 20%
- ✓
Shareholder Friendly
Share count is shrinking, so each share owns more of the company.
−0.5%
5Y share count shrinking (Δ < 0)
- ✓
Manageable Debt
Long-term debt could be cleared with just a few years of cash flow.
0.0×
Long-term debt / 5Y FCF < 5×
- ✓
Growing Cash Flow
The actual cash the business throws off keeps rising.
+7.4%
5Y cash-flow growth > 0
- ✓
Good Cash Generation relative to Price
You pay a fair price for every dollar of cash the company generates.
10.0×
TTM P/FCF < 22.5×
Five-year growth
Finrys data (total growth over the health-check window).
Notice the shape: sales grew, profit grew less, and cash flow barely moved. The engine still runs — it is just losing power. And in 2025 it went into reverse: revenue -10.6% to $8.67M, net income -8.6% to $5.11M, and the loan book shrank from $65.97M to $60.67M.
The catch
The number that isn’t on the report
Here is the single most important thing to understand before you trust any of the ratios above. A lender’s risk does not live in its margins — it lives in its loan book. And Manhattan Bridge carries an allowance for credit losses of exactly zero. Not a small one. Zero. Management’s justification is a genuinely remarkable record: 1,340+ loans since 2007, not one completed foreclosure. On that history, zero is arguably honest.
But look at how the book stays clean. Of the $60.67M outstanding at year-end, about $39.81M consists of loans that are already past their original due date — including one that was due in 2016 — and are still counted as performing because, in the 10-K’s own words, the borrowers “have either signed an extension agreement or are in the process of signing” one.
The loan book by original due date
FY2025 10-K. Everything right of the first bar has been rolled past its own maturity — $39.81M of the $60.67M book, with $19.52M of it rolling for more than a year.
The dividend
A 10% yield that just got smaller
This is what you are actually buying. The quarterly dividend is $0.11 a share — $0.44 a year, a 10.2% yield at $4.30. That is a genuinely high income stream, and it is paid in cash, quarterly, by a company with no meaningful debt.
But it was $0.115 until February 2026, when the board cut it. That is a small cut, and small cuts are easy to wave away — except that this one is the arithmetic catching up. For FY2025 the company declared roughly 103% of its reported profit as dividends. When the loan book shrinks, interest income shrinks with it, and a REIT paying out everything it earns has only one lever left.
10.2%
Dividend yield
paid quarterly
$0.11
Quarterly dividend
cut from $0.115 in Feb 2026
103%
Payout ratio
of FY2025 profit
Valuation
Why a 9.8× P/E can still be “overvalued”
Our model puts fair value at $3.77 — below the $4.30 price — and calls the stock Overvalued. On a 9.8× P/E, that sounds absurd. It isn’t, and the reason is worth understanding, because it applies to every lender you will ever screen.
$3.77
Finrys fair value
$2.64
Buy below (30% MoS)
$2.51
Phil Town sticker
$4.31
10-Cap (deep value)
Valuation anchors vs. price
Finrys outputs across four methods. Dashed line = price ($4.30). Three of the four sit below it.
For the Finrys investor
What this means for you
Manhattan Bridge is the mirror image of the wide-moat names we usually write about. Adobe is a great business at a questionable price. This is a well-run business at a fair price — and the question is not whether it is cheap, but whether the income is durable.
The other side
Risks to keep in view
A zero credit-loss allowance leaves no cushion
The company carries no allowance for credit losses at all — not a small one, zero. That is defensible given a spotless history, but it means the first real loss lands directly in net income with nothing to absorb it. A single maximum-size $4M loan going bad would wipe out roughly three-quarters of a year’s profit.
Two-thirds of the book is past its original due date
Loans originally due in 2016, 2020, 2022, 2023, 2024 and 2025 — about $39.8M of the $60.7M book — are still outstanding, carried as performing because the borrower "has signed, or is in the process of signing" an extension. The auditor flagged the zero allowance as a Critical Audit Matter for exactly this reason. Extensions can be ordinary bridge-lending practice; they can also be how a problem loan stays invisible.
The book is shrinking, and the dividend followed
Revenue fell 10.6% and the portfolio shrank from $66.0M to $60.7M — despite $22.6M of undrawn bank capacity sitting idle. In February 2026 the quarterly dividend was cut from $0.115 to $0.11. Whether that shrinkage is discipline (refusing bad loans) or lost competitiveness is the single most important open question on this stock.
93% of the collateral is in one metro area
Nearly every loan is secured by property in the New York metro area. This is not a diversified lender — it is a leveraged bet on one regional property market, and it has never been tested through a genuine NY price decline with a book this heavily extended.
Micro-cap illiquidity
At a ~$49.2M market cap and roughly 40,000 shares of daily volume, this is a stock you can walk into far more easily than you can walk out of. Position sizing matters more than usual.
Bottom line
So, is Manhattan Bridge a buy?
On business quality, it is far better than its size suggests: 11.6% returns on capital, 0.45× leverage, no dilution, a founder with 22.8% of the shares, and a credit record — zero foreclosures in 1,340+ loans — that most lenders would kill for. On price, our model says you are paying about what it is worth: fair value $3.77 against a $4.30 price, with the 10-Cap landing almost exactly on today’s quote. What you get for that price is a 10.2% yield from a shrinking loan book, backed by a zero credit-loss allowance whose credibility rests on extensions the auditor has formally flagged. If the extensions are what management says they are, this is a solid income holding that will never make you rich. If they aren’t, the first loss lands straight in the earnings — and there is nothing set aside to catch it. Track it on Finrys, decide which of those you believe, and size the position accordingly.